Guidelines

Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions

Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, Vienna, Austria;Ludwig Boltzmann Institute for Hematology & Oncology, Vienna, Austria
Department of Pathology, Texas Tech University Health Sciences Center, El Paso, TX, USA
Department of Medicine, Vanderbilt University School of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, TN, USA
Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA
Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy
Department of Hematology, Amsterdam UMC, location VU University Medical Center, Cancer Center Amsterdam, the Netherlands
Clinic of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany
MLL Munich Leukemia Laboratory, Munich, Germany
Department of Molecular Medicine, University of Pavia, Pavia, Italy
3rd Medical Department with Hematology and Medical Oncology, Hemostaseology, Rheumatology and Infectious Diseases, Paracelsus Medical University, Salzburg, Austria
MLL Munich Leukemia Laboratory, Munich, Germany
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria
Clinic of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany
Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, Vienna, Austria
Department of Medicine I, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany
Children’s Cancer Research Institute and Department of Pediatrics, Medical University of Vienna, Vienna, Austria
Institute of Pathology, Paracelsus Medical University, Salzburg, Austria
Department of Hematology and Oncology, University Hospital Mannheim, University of Heidelberg, Mannheim, Germany
Department of Tumor Immunology-Nijmegen Center for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands
Ludwig Boltzmann Institute for Hematology & Oncology, Vienna, Austria;3rd Medical Department, Hanusch Hospital, Vienna, Vienna, Austria
Sigmund Freud University, Vienna, Austria
Malignant Hematology Department, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA
Huntsman Cancer Institute & Division of Hematology and Hematologic Malignancies, University of Utah, Salt Lake City, UT, USA
Servicio Central de Citometría, Centro de Investigación del Cáncer (IBMCC, CSIC-USAL), CIBERONC and IBSAL, Universidad de Salamanca, Salamanca, Spain
Institute of Pathology, Ludwig-Maximilians University, Munich, Germany
Stanford University Cancer Institute, Stanford, CA, USA
Department of Pathology, University of Chicago, Chicago, IL, USA
Department of Molecular Medicine, University of Pavia, Pavia, Italy
Department of Pathology, Hematopathology Unit and James P Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA
Vol. 104 No. 10 (2019): October, 2019 https://doi.org/10.3324/haematol.2019.222059